Age-Related Macular Degeneration Therapeutics Market is expected to grow at a significant CAGR during the forecast period. Age-related macular degeneration (AMD), commonly known as macular degeneration, is a disorder in which the macula of the retina thins, resulting in loss of central vision. Age-related macular degeneration is most common in the elderly population and can result in permanent visual loss in those aged 60 and up.
Dry age-related macular degeneration (Dry AMD) and wet age-related macular degeneration (Wet AMD) are the two kinds of age-related macular degeneration (wet AMD). Dry age-related macular degeneration is the most prevalent type of macular degeneration, in which the macula thins with age and central vision is lost. Dry age-related macular degeneration does not have a treatment. The less prevalent variety of age-related macular degeneration is wet age-related macular degeneration, which is marked by the proliferation of aberrant blood vessels behind the retina. Anti-vascular endothelial growth factor (anti-VEGF) injections can be used to treat wet age-related macular degeneration.
During the forecast period, the global age-related macular degeneration therapeutics market is expected to be driven by an increase in the geriatric population. According to the World Population Prospects report from 2017, the global population over 60 years old was 962 million, with a projected increase to roughly 2.1 billion by 2050. Globally, the population of people aged 60 and over is growing at a greater rate than all other age categories. This population is particularly vulnerable to age-related disorders such as diabetes, renal insufficiency, arthritis, and macular degeneration. People between the ages of 50 and 59 have a 2% chance of developing advanced age-related macular degeneration, however, those above the age of 75 have a 30% chance. Therefore, the rising prevalence of age-related macular degeneration is expected to boost the market growth.
To Request a Sample of our Report on Age-Related Macular Degeneration Therapeutics Market: https://www.omrglobal.com/request-sample/age-related-macular-degeneration-therapeutics-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2022-2030
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Novartis International AG, Bayer AG, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd. Pfizer Inc., Amgen Inc among others.
Age-Related Macular Degeneration Therapeutics Market Report Segmentation
By Type
- Dry Age-Related Macular Degeneration
- Wet Age-Related Macular Degeneration
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Drug Type
- Brolucizumab
- Bevacizumab
- Ranibizumab
- Pegaptanib
- Aflibercept
- Others
A full Report of Age-Related Macular Degeneration Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/age-related-macular-degeneration-therapeutics-market
Age-Related Macular Degeneration Therapeutics Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/age-related-macular-degeneration-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
